Apyx Medical Corp
Apyx Medical Corp (APYX) Covered Calls
Apyx Medical Corp trades in the Medical Devices industry with an IV Rank of 48.02%, average versus the past year. APYX's highest covered call setup is the $7.50 strike expiring May 21, 2027, sorted by theoretical annualized return. It's 159.52% out of the money with 190 days to expiration, a 162.98% return until expiration, and a 313.09% theoretical annualized return. Across the setups shown, annualized returns run from 88.72% to 313.09% at strikes between $5.00 and $7.50, with 99 to 400 days to expiration, as of Nov 12, 2026.
Read more
Running APYX covered calls helps you generate income from Apyx Medical Corp shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best APYX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If APYX stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling APYX covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given APYX covered call is worth writing.
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market.
| 2027-05-21 | 190 | 7.50 | 159.52 | 0.10 | 0.25 | 471.00 | 162.98 | 313.09 | -3.46 | +0.20 | 0 | 0.15 |
| 2027-02-19 | 99 | 5.00 | 73.01 | 0.05 | 0.25 | 216.00 | 74.74 | 275.56 | -1.73 | +0.22 | 5 | 0.20 |
| 2027-03-19 | 127 | 5.00 | 73.01 | 0.15 | 0.30 | 226.00 | 78.20 | 224.75 | -5.19 | +0.28 | 584 | 0.15 |
| 2027-05-21 | 190 | 5.00 | 73.01 | 0.30 | 0.50 | 241.00 | 83.39 | 160.20 | -10.38 | +0.38 | 4 | 0.20 |
| 2027-12-17 | 400 | 7.50 | 159.52 | 0.40 | 0.65 | 501.00 | 173.36 | 158.19 | -13.84 | +0.39 | 2 | 0.25 |
| 2027-12-17 | 400 | 5.00 | 73.01 | 0.70 | 0.95 | 281.00 | 97.23 | 88.72 | -24.22 | +0.54 | 4 | 0.25 |
As of Nov 12, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV Rank48.02% Moderate
- Market cap (M$)118
- 52 weeks high-44.69%
- 52 weeks low24.89%
- Analyst recommendationStrong Buy
1.00 - Target price$6.50
131.32% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-0.19
- EPS growth next 5 years31.97%
As of Nov 13, 2026